Biology – Page 4
-
FeatureWho will pay for new antibiotics?
Governments around the world are starting to consider alternative funding models and incentives for antibiotics. Katrina Megget asks if it is enough
-
ResearchA force against fungi
With antifungal resistance on the rise, Leah Cowen’s lab wants to identify molecules that can capitalise on vulnerabilities in fungal pathogens
-
FeatureCharting the rise in antimicrobial resistance
We look at the data behind antibiotic drug discovery and development, bacterial resistance and the financial problems with the current business model
-
ResearchMapping antibiotic’s binding of its target points to way to give drugs the killer edge
Technique that creates a comprehensive catalogue of mutations in antibiotic’s target reveals how drugs might be improved
-
WebinarAntimicrobial resistance: Exploring the One Health perspective and wastewater monitoring
The challenges created by antimicrobial resistance are only set to grow. Join us to equip yourself with the most up-to-date facts and knowledge
-
ResearchSynthetic peptide mimics can act as antivirals
Peptoids disrupt enveloped viruses’ lipid membranes as well as targeting fungi and bacteria
-
ResearchRevived Neanderthal and Denisovan peptides show antibiotic activity
Molecular-scale ‘Jurassic Park’ process could uncover new medicines
-
NewsScientists hope to illuminate unknown human proteins with new public database
‘Unknome’ database contains thousands of understudied proteins
-
NewsJustice for Henrietta Lacks as family reaches settlement with Thermo Fisher
Company was accused of profiting from HeLa cells derived from Lacks’ tumour without her family’s approval
-
ResearchClick chemistry offers new, efficient process to produce unique cancer-fighting antibodies
Chemical approach is fast and flexible and could be an alternative o using protein engineering
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
BusinessBiogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
ResearchProtein folding stability set to be unravelled on a massive scale
Technique can analyse a million protein sequences at a time to provide data for machine learning models
-
ResearchCrispr editing reduces poplar lignin content
Gene-edited wood could reduce waste and save energy during pulping process
-
FeatureThe science behind a ‘runner’s high’
Exercise addicts need to stop talking about getting their endorphin hit, writes Hayley Bennett, and start looking at endocannabinoids
-
ResearchAir monitor detects airborne virus particles in real time
Device that detects Sars-CoV-2 could be adapted to monitor other respiratory pathogens
-
NewsEuropean Commission set to propose an overhaul of rules for gene-edited crops
Leaked document reveals light touch regulation planned for crops engineering using precision techniques
-
ResearchLateral flow HPV test could increase detection rates in resource-poor settings
Low-cost assay works uses self-collected samples and gives results within 45 minutes
-
ResearchBiocatalytic process shows promise for large-scale medicinal oligonucleotide production
Promising nucleic acid therapies could be made more cheaply, greenly and simply
-
FeatureMaking replacement organs
From iron lungs to smartphone-controlled insulin pumps, Clare Sansom looks at the efforts to create artificial organs